{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:37:05Z","timestamp":1792006625972,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tiv.2021.105155","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T12:15:50Z","timestamp":1616847350000},"page":"105155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Anticancer effects of non-steroidal anti-inflammatory drugs against cancer cells and cancer stem cells"],"prefix":"10.1016","volume":"74","author":[{"given":"Keisuke","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Furugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2021.105155_bb0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2015.01.001","article-title":"Cancer stem cells: the promise and the potential","volume":"42","author":"Ajani","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.tiv.2021.105155_bb0010","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1002\/jcp.28271","article-title":"Current approaches in identification and isolation of cancer stem cells","volume":"11","author":"Akbarzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tiv.2021.105155_bb0015","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tiv.2021.105155_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1523-1755.2005.00443.x","article-title":"Cystine and glutamate transport in renal epithelial cells transfected with human system xc\u2212","volume":"68","author":"Bridges","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.tiv.2021.105155_bb0025","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00405-012-2029-0","article-title":"Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models","volume":"269","author":"Casares","year":"2012","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.tiv.2021.105155_bb0030","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.18632\/oncotarget.1745","article-title":"Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN","volume":"5","author":"Chu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.tiv.2021.105155_bb0035","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1523\/JNEUROSCI.2459-07.2007","article-title":"System xc\u2212 activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury","volume":"27","author":"Fogal","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tiv.2021.105155_bb0040","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Gr\u00f6sch","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.tiv.2021.105155_bb0045","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.redox.2014.04.008","article-title":"Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance","volume":"2","author":"Ishii","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2021.105155_bb0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc\u2212 and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tiv.2021.105155_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.tiv.2021.105155_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-016-0378-2","article-title":"Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K\/Akt pathway","volume":"17","author":"Liu","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tiv.2021.105155_bb0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcp.21366","article-title":"The xc\u2212 cystine\/glutamate antiporter: a potential target for therapy of cancer and other diseases","volume":"215","author":"Lo","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tiv.2021.105155_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0090-6980(02)00028-X","article-title":"Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2","volume":"68\u201369","author":"Loftin","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tiv.2021.105155_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.28381","article-title":"Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH\/HES1 and activating PPARG in colorectal cancer","volume":"134","author":"Moon","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tiv.2021.105155_bb0080","first-page":"345","article-title":"Aspirin and COX-2 inhibitor use in patients with stage III colon cancer","volume":"107","author":"Ng","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tiv.2021.105155_bb0085","doi-asserted-by":"crossref","first-page":"173339","DOI":"10.1016\/j.ejphar.2020.173339","article-title":"Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo","volume":"884","author":"Okamoto","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tiv.2021.105155_bb0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbrc.2020.07.040","article-title":"Different mechanisms of cisplatin resistance development in human lung cancer cells","volume":"530","author":"Okamoto","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2021.105155_bb0095","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.tiv.2021.105155_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2017.01.002","article-title":"Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition","volume":"104","author":"Roh","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2021.105155_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.tiv.2021.105155_bb0110","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1038\/s41598-017-07005-1","article-title":"Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells","volume":"7","author":"Sonego","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2021.105155_bb0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.tiv.2021.105155_bb0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tiv.2021.105155_bb0125","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/cas.13728","article-title":"High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: potential targets by sulfasalazine","volume":"109","author":"Wada","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tiv.2021.105155_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tiv.2021.105155_bb0135","series-title":"Cancer Pain Relief: With a Guide to Opioid Availability","year":"1996"},{"key":"10.1016\/j.tiv.2021.105155_bb0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2016.02.008","article-title":"Cancer stem cells and chemoresistance: the smartest survives the raid","volume":"160","author":"Zhao","year":"2016","journal-title":"Pharmacol. Ther."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233321000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233321000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:17Z","timestamp":1760135837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233321000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":28,"alternative-id":["S0887233321000801"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105155","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer effects of non-steroidal anti-inflammatory drugs against cancer cells and cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105155"}}